ABSTRACT: Background: Since the validation of carotid endarterectomy (CEA) as an effective means of stroke prevention, there has been renewed interest in its best indications and methods, as well as in how it compares to carotid angioplasty and stenting (CAS). This review examines these topics, as well as the investigation of carotid stenosis and the role of auditing and reporting CEAresults. Investigation: Brain imaging with CTor MRI should be obtained in patients considered for CEA, in order to document infarction and rule out mass lesions. Carotid investigation begins with ultrasound and, if results agree with subsequent, good-quality MRAor CTangiography, treatment can be planned and catheter angiography avoided. An equally acceptable approach is to proceed directly from ultrasound to catheter angiography, which is still the gold-standard in carotid artery assessment. Indications: Appropriate patients for CEA are those symptomatic with transient ischemic attacks or nondisabling stroke due to 70-99% carotid stenosis; the maximum allowable stroke and death rate being 6%. Uncertain candidates for CEA are those with 50 -69% symptomatic stenosis, and those with asymptomatic stenosis ≥ 60% but, if selected carefully on the basis of additional risk factors (related to both the carotid plaque and certain patient characteristics), some will benefit from surgery. Asymptomatic patients will only benefit if surgery can be provided with exceptionally low major complication rates (3% or less). Inappropriate patients are those with less than 50% symptomatic or 60% asymptomatic stenosis, and those with unstable medical or neurological conditions. Techniques: Carotid endarterectomy can be performed with either regional or general anaesthesia and, for the latter, there are a number of monitoring techniques available to assess cerebral perfusion during carotid cross-clamping. While monitoring cannot be considered mandatory and no single monitoring technique has emerged as being clearly superior, EEG is most commonly used. "Eversion" endarterectomy is a variation in surgical technique, and there is some evidence that more widely practiced patch closure may reduce the acute risk of operative stroke and the longerterm risk of recurrent stenosis. Carotid angioplasty and stenting: Experience with this endovascular and less invasive procedure grows, and its technology continues to evolve. Some experienced therapists have reported excellent results in case series and a number of randomized trials are now underway comparing CAS to CEA. However, at this time it is premature to incorporate CAS into routine practice replacing CEA. Auditing: It has been shown that auditing of CEA indications and results with regular feed-back to the operating surgeons can significantly improve the performance of this operation. Carotid endarterectomy auditing is recommended on both local and regional levels.
The use of carotid endarterectomy (CEA) reached peak rates in the mid-1980s but, while enthusiasm was high at that time, evidence of CEA efficacy was low. Rates subsequently fell rapidly as doubts about the benefits and appropriateness of CEA grew. [1] [2] [3] Following the release of randomized clinical trial results positive for CEA, rates in Canada and the United States quickly recovered in the 1990s, [4] [5] [6] [7] [8] [9] with recorded rates between 100 to 400 per 100,000 healthcare beneficiaries in certain US states, 6, 8 and 26 to 83 per 100,000 population among Canada's provinces. 9 The increased performance of CEAseen in recent years has been accompanied by renewed interest in the most eff e c t i v e investigation of carotid stenosis, the selection and risk stratification of patients for surgery, surgical outcomes and in the various anaesthetic and technical aspects of the operation. Finally, CEAfaces a new challenge, and that is its comparison to endovascular correction of carotid stenosis with carotid angioplasty and stenting (CAS).
INVESTIGATION OF CAROTID STENOSIS
Computed tomography (CT) or magnetic resonance imaging (MRI) of the brain is indicated for most patients being considered for CEA, a possible exception being those presenting with classic amaurosis fugax and no hemispheric symptoms. 10 Brain imaging is particularly important in patients with persisting sensory, motor or speech deficits in order to rule out hemorrhage and intracranial mass lesions such as subdural hematomas or tumors which can occasionally present with stroke-like symptoms.
Debate surrounds the need for catheter angiography in assessing symptomatic patients for CEA. Although still the goldstandard in precisely quantifying and characterizing carotid artery stenosis, it is an invasive and uncomfortable investigation, with a combined minor and major complication (primarily stroke) rate approaching 1%. 11 Carotid ultrasound has only moderate accuracy compared to catheter angiography, 1 2 , 1 3 as have CT a n g i o g r a p h y 1 4 and conventional magnetic resonance angiography ( M R A ) . 1 5 , 1 6 The commonest error with ultrasound and standard M R A is overestimation of the degree of stenosis. With that in mind, mild to moderate carotid stenoses (up to 70%) determined by ultrasound or MRA in asymptomatic patients warrant monitoring but usually no further action. An argument can be made, however, that carotid ultrasound indicating more severe stenosis combined with confirmatory MRAor CTangiography is s u fficient to make a decision regarding the need for CEAin many p a t i e n t s . 1 7 , 1 8 A recent review of 40 different studies of imaging and measurement of carotid stenosis found the majority had i n s u fficient methods and standards to inform clinical practice, 1 9 emphasizing the difficulty drawing firm conclusions regarding best and safest carotid imaging at the present time.
Currently, carotid artery investigation usually begins with carotid ultrasound. If significant stenosis is detected, one option is to then proceed to a second noninvasive test, either MRA or CT angiography, and if the results are in agreement with ultrasonography, plan treatment and avoid catheter angiography ( Figure 1 ). This approach would be particularly suitable for patients with symptomatic stenosis where both tests indicate ≥70% and CEA is strongly recommended (Figure 2 of the noninvasive investigations are inconclusive and the possibility remains that the stenosis is nonsurgical or the artery is occluded. In a recent study of 350 patients being investigated for CEA, agreement between carotid ultrasound and MRA results (84% of 350 patients) gave a sensitivity of 96% and specificity of 96% for severe stenosis, compared to reference standard subtraction angiography. 20 Another approach is to follow carotid ultrasonography positive for stenosis with catheter angiography, accepting the small risk associated with the investigation in exchange for the high degree of accuracy catheter angiography provides for stenosis measurement and treatment selection based on randomized trial data. 1 3 , 2 1 Other advantages of catheter angiography include superior demonstration of plaque morphology including plaque length, ulceration, and any attached intraluminal thrombus, determination of the approximate location of the carotid bifurcation in the neck, detection of intracranial atherosclerosis, and assessment of collateral circulation to the hemisphere ( Figure 3 ). T h i s information is useful in determining the relative need for CEAin patients with moderate (50-69%) symptomatic stenosis, discussed further in the next section. In the future it is certain that non-or minimally invasive imaging technique, such as contrast -enhanced MRA [22] [23] [24] will be developed and validated to provide the same information as catheter angiography, eliminating the need for diagnostic catheter studies altogether.
The most widely accepted method of measuring carotid stenosis with angiography compares the narrowest diameter of the residual lumen (on the view showing the greatest stenosis) (N) to the luminal diameter of the internal carotid artery beyond the bulb where the walls of the artery have become parallel (D), and the percentage of stenosis is calculated as (1-N/D) x 100.
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INDICATIONS FOR CAROTID ENDARTERECTOMY
In the past two decades a number of randomized trials have evaluated the benefit and risk of CEA for patients with symptomatic and asymptomatic stenosis of the internal carotid a r t e r y. 2 6 -3 3 Some of the results from the North A m e r i c a n Symptomatic Carotid Endarterectomy Trial (NASCET) are summarized in Table 1 . Sufficient time has passed since the publication of these studies to analyze their results and implications and make general recommendations about the application of CEA based on current knowledge. A number of organizations and experts have published their analyses of the trials, and created guidelines for the use of CEA. [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] Carotid endarterectomy is highly appropriate for patients with symptomatic, severe (70%-99%) stenosis causing either transient ischemic attack (TIA) or nondisabling stroke ( Table 2 ). The maximum allowable rate of all strokes or death in this group of patients is 6%. Patients with symptomatic stenosis in the 50%-69% range are uncertain candidates for CEA in general, but many will benefit if selected on the basis of additional features indicative of a higher stroke risk when treated with medical therapy alone. These factors, which when present, appear to enhance the benefit of CEA (and which pertain to patients with both moderate and severe stenosis) including male sex, 27 a hemisphere as opposed to retinal presentation, 45 a stroke as opposed to TIA presentation, 27 a higher degree of stenosis until "near occlusion" (95% -99%) when the risk declines, 27, 39, 46 plaque ulceration, 4 7 , 4 8 contralateral carotid occlusion, 4 9 t h e presence of intraluminal thrombus, 50 the presence of intracranial ("tandem") atherosclerosis, 51 the absence of collateral pathways to the distal internal carotid artery, 5 2 and the presence of leukoaraiosis (white-matter changes) on brain CT scanning. 53 Asymptomatic patients benefit substantially less from CEA and, for any benefit at all, surgery must be performed with particularly low stroke rates, in the range of 2 or 3% (at least onehalf the stroke rate for symptomatic patients). Selected results from the two randomized controlled trials examining CEA for asymptomatic stenosis are summarized in Table 3 . There may be additional risk factors that increase the risk of an ipsilateral stroke from asymptomatic carotid atherosclerosis. These include male sex, 32 a higher degree of stenosis, 54,55 ipsilateral brain infarction on CTor MRI, 56 plaque ulceration, 57-61 the presence of an occluded contralateral carotid artery, 6 2 a stenosis that progresses over time, 63 a partly echolucent or heterogenous ("soft") plaque or evidence of intraplaque hemorrhage on ultrasound, [63] [64] [65] [66] [67] and the presence of microemboli detected on 68 Asymptomatic stenosis is an uncertain indication for CEA in any circumstance, however, and surgery should only be considered a management option by expert surgeons with very low complication rates in the presence of one or more of these risk factors.
Patients who are inappropriate candidates for CEA are those with less than 50% symptomatic or less than 60% asymptomatic stenosis, and those with unstable medical or neurological conditions, such as unstable angina, recent myocardial infarction, uncontrolled congestive heart failure or progressing major stroke.
While there is a strong association between carotid and coronary artery atherosclerosis, 69 there is limited evidence that the presence of isolated asymptomatic carotid stenosis is an independent risk factor for ipsilateral stroke in patients undergoing coronary bypass surgery. [70] [71] [72] [73] Patients with coronary symptoms and disease which warrant aortocoronary bypass are not often symptomatic from carotid stenosis at the same time, but these patients probably are at higher risk of perioperative stroke when undergoing cardiac surgery, 70, 74 and the carotid stenosis warrants repair for long-term stroke prevention. When this situation arises, options include staged carotid and coronary procedures, 73, 74 combined coronary bypass surgery and CEA, [75] [76] [77] and endovascular treatment of either the carotid or coronary arteries prior to surgical repair of the other. 78, 79 The choice is normally determined by the preference and expertise of surgical teams at individual institutions. At the University of Alberta Hospital, the usual choice is a combined procedure, performing the CEA at the same time as saphenous vein harvesting and closing the neck entirely prior to sternotomy.
TIMING OF CAROTID ENDARTERECTOMY
After a minor and nondisabling cerebral infarct due to carotid stenosis, there is no need to wait weeks or months prior to surgery, as was once thought necessary. 80 Patients with smaller and clinically more minor strokes marked by monoparesis or mild hemiparesis, followed by rapid improvement face no additional risk if operated on early but are afforded earlier protection from recurrent stroke. 8 Patients presenting with TIAs bear a risk for stroke dependent on a number of clinical and plaque-related variables, 83 but the period of maximum risk and precisely how quickly surgery should be performed has not been clearly defined. There is reasonable evidence that patients presenting with hemispheric symptoms, especially if recurrent and due to severe and/or irregular carotid stenosis, should undergo surgery as soon as possible and at least within several weeks of diagnosis, 83, 84 and perhaps sooner if these symptoms occur in a "crescendo" fashion, consist of prolonged (>10 minutes) hemispheric symptoms, recur despite antithrombotic therapy, or ancillary testing suggests ipsilateral cerebral hemodynamic compromise.
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RISK OF CAROTID ENDARTERECTOMY
The major risks of CEAinclude ischemic stroke, intracerebral hemorrhage, myocardial ischemia and infarction, congestive heart failure and arrhythmias, neck hematoma with airway obstruction, and cranial nerve injuries. Ischemic stroke can be due to post-endarterectomy carotid thrombosis and occlusion, thromboembolism from the endarterectomy site and to intraoperative cross-clamp ischemia. 85 Intracerebral hemorrhage is an unusual complication, due to hemorrhagic conversion of a perioperative infarct, postoperative hyperperfusion following repair of a critical stenosis, related to anticoagulation, or a combination of factors. 86 Cranial nerve injuries are relatively common, but usually minor and transient. 87 Neck hematomas can be life-threatening when the airway is compressed. Surgical results of 1415 patients in the NASCETincluded an overall 6.5% rate of all stroke and deaths at 90 days from CEA, most strokes due to thromboembolism, one-third occurring during surgery and two-thirds postoperative. 88 Disabling stroke or death occurred in 2% of patients. Cranial nerve injuries occurred in 8.6% and neck hematomas in 7.1%, although the majority of these local wound complications were mild.
It is clinically useful to be aware of those features associated with a higher risk of surgery in individual patients and a number of authors have correlated clinical and angiographic variables with outcome in order to stratify patient risk for CEA. [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] Consistent predictors of a higher operative stroke and death rate have been hemispheric versus ocular ischemia presentations, female sex, age over 75 years, and occlusion of the opposite carotid artery. Ulceration or irregularity of the carotid plaque was a risk factor in several large series, as was intraluminal thrombus, atherosclerosis in the carotid siphon, peripheral vascular disease, severe hypertension and a history of congestive heart failure. Notably, a number of these features also predict a higher natural history risk of stroke (or risk with medical treatment alone) and, in balance, indicate an even greater benefit from CEA. The presence of one or more of the aforementioned risk factors does not preclude benefit from CEAin many patients with threatened stroke, but does modify the risk of surgery. Contraindications to CEAare shown in Table 4 .
Finally, several recent reports support an impression held by many that repeat or "redo" CEAis associated with a significantly higher perioperative complication rate, related to both cranial nerve injury and stroke. 99, 100 Another recent series has refuted this finding. 101 The advisability of monitoring, the natural history and best management for asymptomatic recurrent carotid stenosis remains quite uncertain. 102 While there appears to be no clear relationship between CEA outcome and surgical specialty, 88 
SURGICALAND ANAESTHETIC TECHNIQUES
There are many variations practiced in the details of CEA surgical and anaesthetic technique. Principles common to all carotid surgeons include: (1) an exposure of the internal carotid artery to beyond where the atherosclerotic plaque is thought to terminate; (2) a meticulous and complete plaque removal, leaving in particular a smooth "distal end" where the plaque bed meets normal intima; (3) a careful arteriotomy closure (or patchangioplasty) ensuring no stenosis or flow disturbance that might lead to postoperative thrombosis or embolism; and (4) declamping the internal carotid artery only after external carotid and common carotid artery reopening, so that no unseen air or debris trapped at or near the repair site be sent to the cerebral circulation when flow is reestablished (Figure 4 ). Careful exposure of the bifurcation reduces the risk of cranial nerve injury, absolute hemostasis reduces the risk of neck hematoma, Table 5 .
Magnification
Although the modern surgical microscope is felt by some to be an adjunct to CEA 107,108 the same is true of any type or degree of magnification used during the procedure. Certainly the microscope, with its variable magnification and superior illumination enhances distal carotid visualization, plaque removal and arteriotomy repair, but it is primarily an instrument available to and used by neurosurgeons. Many surgeons employ operating loupes and headlamps.
Eversion Endarterectomy
This is a technique where the internal carotid artery (ICA) is transected at its origin from the common carotid artery bifurcation, the inner atheroma is grasped and the outer adventitial layer is peeled and everted over the ICAplaque to its distal end and detached. The internal carotid artery is then reanastomosed to the bulb with a running suture. It is inappropriate for patients with significant common carotid artery atheroma and stenosis, and use of a shunt is more difficult than with conventional CEA, but proponents consider the procedure faster, and the risk of recurrent stenosis less. [109] [110] [111] [112] It has been compared to standard CEA in a randomized trial in Europe, without any clear differences apparent in that study 113 or a review of the literature.
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Patch Closure
Possible benefits from the augmented lumen diameter provided by patch angioplasty include a reduced acute thrombosis risk as well as a lower incidence of longer term restenosis. Patch materials commonly used include autologous saphenous vein, various synthetic materials such as polytetrafluorethylene (PFTE; Gore-Tex), the polyester fabric Dacron which is also provided collagen-impregnated, and bovine pericardium. 115 Vein grafts provide an endothelialized luminal surface and the suture lines are especially hemostatic, but they require harvesting and a second wound, and there have been rare reports of postoperative rupture and aneurysm formation associated with vein patches. 116 The use of patch closure varies among surgeons. In NASCET a simple closure was used in 79% of 1,415 patients, a fabric patch in 10% and a vein patch in 10%. 88 Patch closure was more commonly performed by vascular-rather than neurosurgeons, but did not correlate with perioperative stroke risk. Patch closure was used in 28% of 1,729 operations in the European Carotid Surgery Trial, and again there was no association with its use and the risk of stroke or death. 96 In a small study of 74 patients that underwent bilateral CEAs, patch closure on one side (either PFTE or saphenous vein) and primary closure on the other (staged operations in a random sequence), it was found that patching was associated with a lower operative stroke (4% for primary closure versus 0% for patching), lower incidence of ultrasound-detected restenosis (22% versus 1%) and better cumulative patency rate, differences The nerve can be applied to an overlying facial vein (especially a higher one) and should be avoided each time a vein overlying the carotid bifurcation is divided. When the nerve must be moved for internal carotid artery exposure, cut the descendens hypoglossi and mobilize, rather than retract. If inadvertently divided, the nerve should be reanastomosed with microsutures.
Vagus nerve injury:
Leave the nerve adherent to the internal jugular vein and protect with overlying Cottonoid strip.
Facial nerve (or branch) injury:
Avoid dissection into the parotid gland and replace excessive manual retraction of the apex of the wound (with a right-angle retractor) with fish-hooks.
Accessory nerve injury:
Avoid excessive posterior mobilization of the proximal sternomastoid muscle.
Intraoperative embolization:
Avoid excessive mobilization of the carotid bifurcation from its bed during dissection, expel all air from the internal carotid artery by deoccluding the external carotid artery prior to final arteriotomy closure, and declamp the external carotid artery, common carotid artery, and internal carotid artery in that sequence to send any debris from the common carotid artery into the external carotid artery.
Incomplete plaque removal or rough distal end:
Ensure ample distal internal carotid artery exposure and access before arteriotomy, and use magnification for plaque bed inspection.
Cross-clamp ischemia:
Aim for 30 minutes or less. Consider shunting if EEG, somatosensory evoked potentials, or transcranial Doppler monitoring suggest distal ischemia, if there is scant reflux of blood down the internal carotid artery temporary declamping, or in the setting of contralateral internal carotid artery occlusion or a hypoplastic anterior precommunicating artery.
Distal subintimal dissection:
Use tack-down sutures on loose or prominent distal intimal shelves.
Stenosing arteriotomy closure:
Prevent the arteriotomy from slipping into the crotch of the carotid bifurcation. Use magnification and patch liberally (narrow arteries, long or repeat endarterectomies, and problematic distal ends).
Neck hematoma:
Maintain absolute hemostasis throughout (bi-and monopolar cautery dissection and/or hemostatic scalpel). Use suture ligatures rather than simple suture ties on facial veins. Pay special attention to patients on ticlopidine or clopidrogrel preoperatively. that were all statistically significant. 117 These results concur with a prior randomized trial by the same group comparing the two techniques in different patients, 118 and with a systematic analysis of the literature on the subject. 119 Outcome differences between vein and synthetic patches have not been detected. 120, 121 There appears to be benefit in a liberal or possibly even routine use of patches, but the choice of patch material seems less important at this time. Although their selection is often arbitrary, patients who might be the most logical candidates for patch closure are those with either small internal carotid arteries or long plaques and arteriotomies (i.e. < 5mm and > 20 mm, respectively), patients undergoing repeat endarterectomy, and those patients who are considered young for CEA (i.e. age less than 60 years). Given the number of variables involved, it is understandable that some surgeons have adopted a "patch all" policy, and immediately available synthetic grafts have only simplified this decision.
Carotid Occlusion
A number of studies have proven the feasibility of reopening acutely occluded ICAs, successful cases usually being those presenting with a TIA or minor stroke (and therefore adequate collateral blood flow to prevent a major hemispheric infarct with the loss of the ICA) who are found on angiography to have retrograde reflux filling from collateral sources to the level of the petrous or distal cervical ICA. 1 2 2 -1 2 5 To be successful, deocclusion must be undertaken early, preferably within several days. Whether or not the benefit of reopening a carotid outweighs the risk of the patient who has tolerated its loss is open to question. Advocates point to studies indicating a roughly 5% annual stroke risk distal to an occluded ICA. 126 The specifics of carotid thrombectomy require description. Following exposure of the carotid bifurcation, passage of vessel loops around the common, external and internal carotid arteries, and systemic heparinization, only the common and external carotid arteries are occluded. An arteriotomy is made, exposing a column of thrombus distal to the stenosis. In the best of circumstances, suction and mechanical traction on the thrombus with forceps will retrieve the entire column of clot from the internal carotid artery, propelled and followed by retrograde bleeding. In many patients, however, a no. 2 Fogarty catheter needs to be passed up the internal carotid artery 10 -12 cm (or until resistance is felt, whereupon the catheter should be withdrawn 1 cm), its balloon inflated, and the catheter withdrawn, retrieving thrombus and hopefully followed by backbleeding. If, after several attempts, little or no back-bleeding is established, the ICA should be ligated. If retrograde bleeding is established, a regular CEA should be carried out and flow restored up the internal carotid artery. In these circumstances, an intraoperative completion angiogram should be considered. A danger of this maneuver is the creation of a carotid-cavernous fistula, so care must be taken not to advance the catheter too far, or against resistance.
Intraoperative Carotid Imaging
Some surgeons consider intraoperative vascular imaging either with ultrasound, angioscopy or angiography useful in ruling out technical errors in the repair such as an intimal flap, although the usefulness of this in reducing operative stroke risk has not been shown.
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Anaesthesia and Monitoring
Anaesthetic and perioperative risk in patients presenting for CEA is significantly increased by the frequently accompanying co-morbidities of ischemic heart disease, peripheral vascular disease, hypertension, obesity, diabetes and respiratory disease.
General anaesthesia remains the predominant anaesthetic technique for CEA. [131] [132] [133] [134] The goals in the management of patients undergoing general anaesthesia for CEAare to maintain cerebral perfusion pressure without unduly increasing myocardial oxygen demands and to ensure rapid emergence and return to an alert state in order to facilitate prompt postoperative neurological assessment. The advantages of general anaesthesia include guaranteed immobility, optimum patient positioning, lack of pressure to complete a procedure in a patient who is restless or uncomfortable and excellent control of oxygenation and ventilation. Most general anaesthetics reduce the cerebral metabolic rate of oxygen and may improve cerebral tolerance to ischemia. The major disadvantage of general anaesthesia is the loss of ability to assess the adequacy of cerebral perfusion, particularly at the time of carotid clamping. The availability of a monitor which accurately detects significantly impaired cerebral perfusion could direct therapeutic interventions such as deliberate hypertension, use of potentially neuroprotective drugs and carotid shunting.
Unfortunately, a highly sensitive and specific monitor of cerebral perfusion for use in the intraoperative setting does not exist. No monitoring modality has emerged as clearly superior and consequently there is wide variation in clinical practice. The monitoring modalities which have been studied in CEA include stump pressure, EEG, somatosensory evoked potentials (SSEP), transcranial Doppler (TCD), and near infrared spectroscopy or cerebral oximetry.
Measurement of stump pressure was one of the earliest techniques used in an attempt to measure the adequacy of collateral flow after carotid clamping. The threshold pressure considered to be significant varies widely among studies. Overall predictive value for new neurological deficits is low. 135 Electroencephalography has a long history of use in CEA 136 and is probably the monitor most commonly currently used. An EEG primarily reflects changes in cortical activity and may not reflect ischemia in subcortical structures. Cortical activity is monitored only in the area beneath the overlying electrode and therefore the ability to detect ischemia is affected by the number of leads and their position. The EEG interpretation will be complicated by presence of anaesthetic agents, 137 changes in anaesthetic depth and the presence of pre-existing stroke.
Unlike EEG, SSEPs are sensitive to both cortical and subcortical ischemia. Advantages of SSEP monitoring include less sensitivity to anaesthetic effect than EEG and some utility in the presence of previous stroke. 138 Reported sensitivities and specificities for SSEPs predicting postoperative neurologic deficits are variable.
Changes in middle cerebral artery flow velocity as measured by TCD have been used as markers for ischemia during CEA. 139 Unlike all of the other CEA monitoring modalities, which are primarily focused on detecting hemodynamic events resulting in cerebral ischemia, TCD can be used to detect embolic events as they occur. Detection of emboli allows for possible alteration of surgical technique. Significant numbers of emboli on closure may indicate impending luminal thrombosis. 140 Transcranial Doppler may also be useful in predicting postoperative hyperperfusion syndrome. 141 With cerebral oximetry or near infrared spectroscopy, oxygen saturation of hemoglobin contained in arteries, veins and capillaries is measured by a sensor placed in direct contact with scalp. Sensor placement, regional variation in flow and contamination by extracranial blood flow may all introduce errors. Thresholds for identification of ischemia have been d i fficult to define 1 4 2 with variable predictive values for postoperative deficit. 143 There has been an increasing interest in the use of regional anaesthesia for CEA. A combination of deep and superficial cervical plexus block appears to be the most common technique. Superficial block alone may be as effective as combined block with potentially fewer complications. 1 4 4 An additional mandibular nerve block may be helpful in alleviating jaw pain in patients with high carotid bifurcations. 145 The major advantage to regional anaesthesia is the ability to continuously monitor neurologic function which obviates the need for additional cerebral monitoring and allows for highly selective shunt placement, and some believe regional anaesthesia may be associated with a smaller incidence of cardiopulmonary disturbances and a shorter hospital stay. The disadvantages are difficult airway access in emergent circumstances, frequent intraoperative hypertension and the requirement for a cooperative patient.
Debate continues as to the influence of anaesthetic technique upon postoperative morbidity and mortality. There is no clear evidence that postoperative stroke rates are influenced by anaesthetic technique. A large prospective randomized trial is required to address this issue definitively. 146 The authors' (J.M. Findlay and B.E. Marchak) preference is general anaesthesia in order to position the patient for use of the operating diploscope, in combination with intraoperative EEG monitoring for crossclamp ischemia and selective shunt use.
PERIOPERATIVE MANAGEMENT
All patients should receive antiplatelets before CEA, usually aspirin at a dosage of at least 81 mg per day, to reduce the risk of postoperative stroke. 147 Intravenous heparin can be continued right until the moment of surgery, oral anticoagulation should be completely reversed, and while patients receiving clopidogrel can undergo CEA, they require special attention with respect to arteriotomy and wound hemostasis (ie. complete reversal of intraoperatively administered heparin).
The routine postoperative care of CEA patients has changed significantly in recent years. 148, 149 Because of a high incidence of coexistent cardiac disease and hypertension, and a greater amount of hemodynamic instability than most surgical patients exhibit, a step-down or close-observation unit for 12 hours or overnight post-CEA(with an indwelling arterial line and cardiac telemetry) is appropriate. Patients can be safely discharged after a total of two to three days in hospital if there have been no complications.
Bradycardia and hypotension are common in the first 12 hours following CEA, and are usually responsive to intravenous atropine. Care must be taken not to induce hypervolemia with repeated fluid boluses if the patient has a history of congestive heart failure, and a vasopressor agent is rarely required. Significant hypertension usually responds to intravenous labetolol.
Neck Hematomas
Neck hematomas complicating CEA can be life-threatening. Among the 1,415 surgical patients in NASCET, neck hematomas were recorded in 101 (7%), one-half of these required a return to the operating room or delayed discharge, and two patients died from airway obstruction. 88 An arteriotomy or patch dehiscence (carotid "blow-out") is fortunately very rare, since it can be rapidly fatal. Patients should be constantly checked in the first few hours following CEA, and while mild hematomas not causing pain or difficulty breathing may stabilize with pressure, hematomas causing any degree of stridor or distress are most safely treated by surgical evacuation of the clots.
In more extreme circumstances of frank hypoxia with imminent respiratory arrest, emergency intubation should be performed by a skilled anaesthetist, in the operating room if at all possible. Intubation is difficult, and urgent surgery must follow. If the hematoma causes enough airway distortion to prevent visualization of the vocal cords, then the wound should be immediately opened to decompress the airway and an attempt at intubation repeated. Tracheostomy under these circumstances is a last resort. It is sometimes difficult to locate the precise source of bleeding in these patients once an airway is secured and the wound is opened for thorough exploration. Following surgical evacuation of a neck hematoma patients should remain intubated at least overnight and until swelling begins to subside and an air leak is detected around the endotracheal tube when the cuff is deflated.
Postoperative Stroke
The majority of strokes occur during or within 12 hours of surgery, and ICA thrombosis or thromboembolism account for the majority. 150 Hemorrhage is a rare cause of postoperative stroke, often related to repair of a critical stenosis in the presence of a distal infarct in a hypertensive patient. 86 In NASCET's 1,415 surgical patients there were only two postoperative intracerebral hemorrhages. 88 In the setting of an acute postoperative stroke causing hemiparesis or hemiplegia, most authorities have recommended either urgent surgical re-exploration or cerebral angiography with the goal of reopening occluded vessels and correcting flaws in the arterial repair. However, there is some question as to the efficacy of these approaches in reversing stroke. The surgical results of NASCET include 10 patients who underwent emergency reoperation for major hemispheric strokes, eight of whom had occluded arteries which were reopened, but none benefited. 88 Others have reported more favorable results from an aggressive surgical approach to acute postoperative stroke. 151 A recent review of 700 consecutive CEA procedures examined in 13 patients who experienced major hemispheric deficits (hemiplegia with or without aphasia, forced eye deviation, and decreased consciousness) that prompted either immediate surgical re-exploration or cerebral angiography with reoperation on the basis of angiogram results. 85 Approximately one-half had an underlying, correctable lesion (endarterectomy site occlusion or stenosis), and these patients typically had strokes that occurred after the patient awoke from surgery. Approximately one-half of these patients improved as a result of immediate reopening, although new infarcts were seen in almost all on CT scanning.
The options for an aggressive approach include immediate carotid imaging with ultrasound or contrast angiography, s u rgical re-exploration of the operative site, or perhaps a combination of the two if intraoperative cerebral angiography is available. If available, prompt cerebral angiography best directs further management, which might include endovascular management with thrombolysis or stents.
1 5 2 -1 5 5 C o m p u t e d tomography of the brain is less profitable in the first several hours following CEA, given the rarity of acute intracerebral hemorrhage after CEA. The course of action chosen, usually on the basis of the suspected cause of stroke, timing of its onset, and the speed with which either angiography or surgery can be performed, is aimed at detecting and correcting carotid occlusion or significant residual stenosis ( Table 6 ). As with all types of acute and potentially reversible ischemic stroke, speed is of the essence. On occasion, this can result in an important, early neurological improvement.
Carotid Angioplasty and Stenting
The popularity of CAS for the treatment of carotid stenosis continues to grow ( Figure 5 ). There is good evidence that in experienced hands CAS can be a safe and effective alternative to CEA in selected patients. 156, 157 In the largest single center CAS case series reported to date, the major and minor stroke rates were 1% and 4.8%, respectively, and the overall stroke and death rate at 30 days was 7.4%. 18 A world-wide survey of CAS procedures done in 2000 158 and recently updated 159 indicates a major stroke rate at 30 days of 1.2%, and a minor stroke rate of 2.1% in over 11,000 treated vessels. The overall stroke and death rate in that survey was 4.8%, and the restenosis rate at 36 months was only 2.4%. The technology of CAS continues to evolve, and a variety of neuroprotective devices to catch emboli during the procedure are now commercially available. 160, 161 Others are being tested in a number of different registries. Early reports indicate that these devices can help lower the neurological complication rates to as low as 1.3%. 160 Drug-eluting and bioactive stents designed to reduce the risk of restenosis are presently used in coronary arteries, and will likely soon find neurovascular applications. Carotid angioplasty and stenting can be performed as an outpatient procedure on ambulatory patients 162 and CAS is possible in patients with significant medical co-morbidities associated with higher surg i c a l risks. 163, 164 However, there have been concerns expressed about the quality of evidence supporting widespread adoption of CAS as an alternative to CEA at this time. [165] [166] [167] These include the large number of single-center series reported thus far, the mixture of symptomatic and asymptomatic patients in many of those series, and the quality and consistency of neurological follow-up. The few direct comparison studies between CAS and CEA, including the Carotid and Vertebral Artery Transluminal Angioplasty Study have shown CAS outcomes that are either the same or worse than CEA. 168, 169 As already discussed, CEA is of more marginal clinical benefit to patients with moderate symptomatic and asymptomatic stenosis, yet patients from these groups have made up a large percentage of many CAS reports. Symptomatic patients are at a higher risk of stroke from CEA t h a n asymptomatic patients, 97 and if the same applies to CAS, this may have biased the complication rates for CAS reported to date.
Although CAS has been proposed as less costly than CEA, this has also been questioned. Two recent reports have shown lower overall costs associated with CEA. 170, 171 Proponents of regional anaesthesia for CEA have also challenged the notion that patients with medical risk-factors should preferentially undergo CAS. 
Focal deficits
• In setting of pre-existing neurodeficit (prior stroke), temporize for 30 minutes because postoperative exacerbation of deficit is common, and gradual movement will be noted.
• If no preoperative deficit was present, postoperative deficit may indicate cerebral angiography to detect flaws in the arterial repair and possibly intra-arterial thrombolysis of distal thromboemboli.
• Perform CT scanning if angiography negative for thromboembolism (to rule out intracranial hemorrhage). Carotid angioplasty and stenting has been performed for over 10 years, and the balance of evidence indicates that experienced interventionalists can achieve good results with this procedure, a situation similar to the status of CEA prior to its validation in randomized trials comparing surgery to medical therapy alone. There are persuasive arguments for the continued use of CAS. 173 Observational data can never substitute randomized controlled trials. 165, 167 There are at least 12 such trials comparing CAS to CEA now underway world-wide. 159 The largest is the Carotid Revascularization Endarterectomy versus Stent Trial (CREST), which after a lengthy initiation 1 7 4 , 1 7 5 is now randomizing patients. In addition to assessing the overall clinical efficacy of CAS compared to CEA, this study will examine differential efficacy between men and women, pre-and postprocedure morbidity, restenosis, differences in quality of life and costeffectiveness, and subgroups of patients at differential risk. CREST plans to randomize 2,200 patients with symptomatic extracranial internal carotid stenosis measured to be 50-99% by angiography over three years, and it has been predicted to take five years to complete the study. As of December 2002, 257 patients from 60 North American sites had been randomized and the rates of neurological complications in the CAS group were 3.6% in asymptomatic patients and 6.6% in symptomatic patients. 159 Until further information is obtained from studies such as CREST, CEAremains the only validated procedure that has been clearly shown to reduce the risk of stroke. Current evidence does not support the incorporation of CAS into routine clinical practice at present. Special circumstances may warrant its current use, such as radiation-induced carotid stenosis, high cervical and surgically inaccessible stenosis, and symptomatic stenosis when there exists a significant medical contraindication to surgery, such as recent myocardial infarction, unstable angina, or uncontrolled congestive heart failure.
A B
CEA "EFFECTIVENESS" AND CEA AUDITING
"Effectiveness" of a medical intervention is the equivalent of efficacy, but measured in the "real world" of clinical practice as opposed to a clinical trial. 1 7 6 While efficacy studies (i.e. randomized controlled trials) can tell us if a procedure can work, effectiveness studies tell us it does work in routine clinical practice.
To achieve maximum effectiveness from CEA, which is the greatest number of strokes prevented in the clinical application of this procedure, two conditions must be met. The first is a reduction of perioperative morbidity and deaths to a minimum. This maximizes the absolute risk reduction (ARR) for stroke, leaving it limited only by the risk of stroke if the stenosis was treated medically. This then leads to the second condition, which is maximizing the appropriateness of patient selection for CEA by choosing those patients at greatest risk of stroke and with the most to gain by CEA. These patients have the highest baseline risk of stroke treated medically, the largest ARR with surgery and the smallest "number needed to treat" (calculated as the inverse of the ARR) to prevent a single stroke over a given number of years. The most effective use of CEA would therefore be in patients at highest risk of stroke without surgery when the operation is carried out with the lowest complication rates.
Although methodological shortcomings are unavoidable in retrospective reviews, a number of recent regional and state-wide surveys have reported acceptable CEA stroke or death complication rates for symptomatic patients, ranging between 3 to 7.5%. 8, 85, 95, 104, 177 Patient selection for CEA has been more variable, as have the criteria for "appropriate" indications. Particularly variable and contentious is designation of asymptomatic patients as "uncertain" or "appropriate". [178] [179] [180] [181] [182] There have also been marked geographical variations in the rate of CEA between countries and regions within countries, most likely reflecting regional clinical practice supply of services. 8, 9, 183, 184 Carotid endarterectomy is well-suited for examination of its outcomes, complications and appropriateness. Indications for C E A have become quite well-defined, and the major events which complicate CEAare readily detected when hospital records are reviewed and patients contacted for follow up. Aregular CEA auditing process implemented in Edmonton providing direct feedback of surgical indications and operative results to operating s u rgeons has been found to result in significant improvements in the "effectiveness" of CEA; both surgical indications and results continued to improve over time. 1 8 5 
